AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AROVELLA THERAPEUTICS LTD

0.061

0.000

Volume:290.49K

Turnover:17.72K

Market Cap:73.74M

PE:-10.52

High:0.061

Open:0.061

Low:0.061

Close:0.061

52wk High:0.125

52wk Low:0.058

Shares:1.21B

Float Shares:895.86M

Volume Ratio:6.94

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.006

ROE:-40.41%

ROA:-26.35%

PB:5.21

PE(LYR):-10.52

Loading ...

Overview Company News Filings

Arovella Therapeutics Ltd-Letter From Managing Director and CEO

THOMSON REUTERS

Arovella Therapeutics Says FDA Accepts Investigational New Drug Application for Blood Cancer Drug Candidate

MT Newswires Live

BRIEF-Arovella Therapeutics Says IND For Ala-101 Accepted By FDA

Arovella Therapeutics Ltd - Ind for Ala-101 Accepted by U.s.FDA

THOMSON REUTERS

BRIEF-Arovella Therapeutics Appoints Lachie Mallia As CFO

Arovella Therapeutics Ltd-Company Secretary/CFO Appointment/Resignation

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/ALA.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","market":"AU","secType":"STK","nameCN":"AROVELLA THERAPEUTICS LTD","latestPrice":0.061,"timestamp":1789088554924,"preClose":0.061,"halted":0,"volume":290492,"delay":0,"changeRate":0,"nameEN":"AROVELLA THERAPEUTICS LTD","floatShares":895858885,"shares":1208783672,"eps":-0.0058,"marketStatus":"Trading","change":0,"latestTime":"09-11 11:05:13 AEST","open":0.061,"high":0.061,"low":0.061,"amount":17720,"amplitude":0,"askPrice":0.061,"askSize":33429,"bidPrice":0.06,"bidSize":65268,"shortable":3,"etf":0,"ttmEps":-0.0058,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789106400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.061,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":6.943065,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ALA.AU","preClose":0.06,"auctionPrice":0.06,"auctionVolume":18085,"auction":3,"marketStatus":"盘后竞价","timestamp":1788934095981}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","floatShares":895858885,"roa":"-26.35%","roe":"-40.41%","lyrEps":-0.0058,"volumeRatio":6.943065,"shares":1208783672,"dividePrice":0,"high":0.061,"amplitude":0,"preClose":0.061,"low":0.061,"week52Low":0.058,"pbRate":"5.21","psRate":"21.08","week52High":0.125,"institutionHeld":0,"latestPrice":0.061,"committee":0.322593,"eps":-0.0058,"divideRate":0,"volume":290492,"delay":0,"ttmEps":-0.0058,"open":0.061,"prevYearClose":0.093,"prevWeekClose":0.061,"prevMonthClose":0.06,"prevQuarterClose":0.062,"fiveDayClose":0.061,"twentyDayClose":0.062,"sixtyDayClose":0.071},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALA.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609165883","title":"Arovella Therapeutics Ltd-Letter From Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609165883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609165883?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:42","pubTimestamp":1770241363,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUE35N0XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607977190","title":"Arovella Therapeutics Says FDA Accepts Investigational New Drug Application for Blood Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2607977190","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607977190?lang=en_us&edition=fundamental","pubTime":"2026-01-29 12:20","pubTimestamp":1769660439,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics (ASX:ALA) said the US Food and Drug Administration (FDA) accepted its investigational new drug application for its ALA-101 drug candidate to commence first-in-human clinical tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK4139","ALA.AU","LENZ","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607209517","title":"BRIEF-Arovella Therapeutics Says IND For Ala-101 Accepted By FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2607209517","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607209517?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:25","pubTimestamp":1769649914,"startTime":"0","endTime":"0","summary":"BRIEF-Arovella Therapeutics Says IND For Ala-101 Accepted By FDAJan 29 (Reuters) - Arovella Therapeutics ALA.AX:IND FOR ALA-101 ACCEPTED BY U.S.FDAFurther company coverage: ALA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT16R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ALA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607093725","title":"Arovella Therapeutics Ltd - Ind for Ala-101 Accepted by U.s.FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2607093725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607093725?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:11","pubTimestamp":1769638314,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605320664","title":"BRIEF-Arovella Therapeutics Appoints Lachie Mallia As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2605320664","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605320664?lang=en_us&edition=fundamental","pubTime":"2026-01-22 08:50","pubTimestamp":1769043049,"startTime":"0","endTime":"0","summary":"BRIEF-Arovella Therapeutics Appoints Lachie Mallia As CFOJan 22 (Reuters) - Arovella Therapeutics Ltd ALA.AX:COMPANY SECRETARY/CFO APPOINTMENT/RESIGNATIONAPPOINTS LACHIE MALLIA AS CFOFurther company coverage: ALA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUE7GGP57:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ALA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605743375","title":"Arovella Therapeutics Ltd-Company Secretary/CFO Appointment/Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2605743375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605743375?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:32","pubTimestamp":1769031124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUE7GGP57:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":26,"code":"91000000","status":"200"}]}}